Uncertain Clinical Effect of Polymyxin B Hemoperfusion in Patients with Septic Acute Kidney Injury Requiring Continuous Renal Replacement Therapy.
Sign Up to like & getrecommendations! Published in 2021 at "Shock"
DOI: 10.1097/shk.0000000000001752
Abstract: ABSTRACT Polymyxin B hemoperfusion (PMX-HP) may improve the clinical outcomes of patients with sepsis and gram-negative bacteremia by reducing endotoxin levels. However, the recent studies with the variable degree of renal support have shown that… read more here.
Keywords: crrt; polymyxin hemoperfusion; continuous renal; day ... See more keywords
Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan
Sign Up to like & getrecommendations! Published in 2021 at "Blood Purification"
DOI: 10.1159/000513213
Abstract: Introduction: Polymyxin B hemoperfusion (PMX) reduces endotoxin in septic shock patients’ blood and can improve hemodynamics and organ functions. However, its effects on the reduction of septic shock mortality are controversial. Methods: Using the Japanese… read more here.
Keywords: polymyxin hemoperfusion; septic shock; group; day ... See more keywords